# Interacting with the FDA on Complex Innovative Trial Designs for Drugs and Biological Products: Guidance for Industry - FDA Guidance Document Source: https://www.globalkeysolutions.net/guidances/guidance-document/interacting-with-the-fda-on-complex-innovative-trial-designs-for-drugs-and-biological-products-guidance-for-industry/915195b1-fcb7-4359-b741-f4ca3ed67b13 > FDA guidance document: Interacting with the FDA on Complex Innovative Trial Designs for Drugs and Biological Products: Guidance for Industry. Issue date: December 16, 2020. Get complete insights and analysis. --- ## Details - Title: Interacting with the FDA on Complex Innovative Trial Designs for Drugs and Biological Products: Guidance for Industry - Communication Type: Guidance Document - Product Type: biologics - Office Name: Center for Biologics Evaluation and Research - Office URL: /offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d - Issue Date: 2020-12-16 - Last Changed: 2024-04-09 - Docket Number: FDA-2019-D-3679 ## Related Documents - [Long Term Follow-up After Administration of Human Gene Therapy Products: Guidance for Industry](https://www.globalkeysolutions.net/guidances/guidance-document/long-term-follow-up-after-administration-of-human-gene-therapy-products-guidance-for-industry/5f3e0db9-8c8a-45b5-864f-6250a3250b1b) - [Recommendations for Screening, Testing, and Management of Blood Donors and Blood and Blood Components Based on Screening Tests for Syphilis: Guidance for Industry](https://www.globalkeysolutions.net/guidances/guidance-document/recommendations-for-screening-testing-and-management-of-blood-donors-and-blood-and-blood-components-based-on-screening-tests-for-syphilis-guidance-for-industry/55e82ed9-047c-4235-9442-7dc1d1a9a4d0) - [Human Gene Therapy for Hemophilia: Guidance for Industry](https://www.globalkeysolutions.net/guidances/guidance-document/human-gene-therapy-for-hemophilia-guidance-for-industry/bceafce9-c9f0-4137-9ca5-071464212a06)